HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

4-Hydroxyhexenal

HCID 5283314
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
109710-37-4
Standard SMILES
CCC(O)/C=C/C=O
InChIKey
JYTUBIHWMKQZRB-ONEGZZNKSA-N
Molecular formula
C6H10O2
Average molar mass
114.14 g/mol
Monoisotopic mass
114.06807956

Overview

4-hydroxyhexenal is a monounsaturated fatty aldehyde.

Names & identifiers

Preferred name
4-Hydroxyhexenal
IUPAC
(E)-4-hydroxyhex-2-enal
English name
4-hydroxy Hexenal
Molecular formula
C6H10O2
Molecular weight
114.14

Names & synonyms

4-Hydroxyhexenal4-hydroxy-2E-hexenalRefChem:912587109710-37-44-hydroxy Hexenal17427-21-3(E)-4-hydroxyhex-2-enal4-HHE(E)-4-Hydroxy-2-hexenal2-Hexenal, 4-hydroxy-, (2E)-(2E)-4-hydroxyhex-2-enal160708-91-8
Show more names
4-hydroxy-2(E)-hexena
CHEMBL5277300(E)-4-HYDROXYHEXENALHexenal, 4-hydroxy-2-HEXENAL, 4-HYDROXY-(2E)-4-hydroxy-2-hexenalCCRIS 9201(E)-4-Hydroxy Hexenal2-Hexenal, 4-hydroxy-, (E)-

Database identifiers

CAS
109710-37-4、17427-08-6、17427-21-3
PubChem CID
5283314
DTXSID
DTXSID701313524
ChEMBL
CHEMBL5277300
ChEBI
CHEBI:180385
Nikkaji
J49.434H、J548.917B

Properties

Computed structural propertiesFilling in

XLogP
0.2
Topological polar surface area
37.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
3
Heavy atoms
8
Formal charge
0
Complexity
86.5

Experimental & physicochemical properties

LipidsFatty Acyls [FA] -> Fatty aldehydes [FA06]

Physicochemical properties

Boiling point
89 · 89-90 °C(Press: 2 Torr)
Density
0.98 · 0.980±0.06 g/cm3(Predicted)
storage temp.
-80 °C · Store at -80°C
solubility
50 mg/ml; · DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: >50 mg/ml; PBS pH 7.2: >1 mg/ml
pka
13.18 · 13.18±0.20(Predicted)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 item

Uremic toxins such as 4-Hydroxyhexenall are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 item

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Chemistry & industry

Pharmacology

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.

Uses & manufacturing

UsesNaturally produced by the body (endogenous).

Applications

Description4-hydroxy Hexenal is a lipid peroxidation product derived from oxidized ω-3 fatty acids such as DHA.

Uses(E)-4-Hydroxy Hexenal is a 4-hydroxyalkenals that induces genotoxic effects in the micromolar range.

Additional notes

DefinitionChEBI: 4-hydroxyhexenal is a fatty aldehyde.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes